Skip to content

GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability

By asianet

GenScript Biotech Corporation (Stock Code: 1548.HK), the world’s leading life science research tools and services provider, today announced the opening of more than 30,000-square-feet facility for highly automated protein and gene preparation services. The state-of-the-art site marks a significant expansion of the company’s advanced protein and gene platforms, and is designed to provide high quality, … Continued

Well Begun AND Half Done! – SIRONA Randomized Trial Achieves fifty percent enrollment

By asianet

Concept Medical Inc., (https://www.conceptmedical.com/) focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooN Angioplasty in the Femoropopliteal Artery), as the trial completes half the targeted enrolment. SIRONA (https://www.conceptmedical.com/press-release/sirona/)is the world’s first and the largest head-to-head RCT investigating the use of Sirolimus … Continued

Bugworks Research Inc. Secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India

By asianet

This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO) Bugworks Research, a clinical stage multi-indication therapeutics company, today announced the financing of US$18M Series B1. This round will support the clinical development of BWC0977, a novel broad spectrum anti-bacterial agent available in both IV and Oral … Continued

Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year

By asianet

Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized by the annual CMO (Contract Manufacturing Organization) Leadership Awards in the categories of Quality and Service. This marks the eighth consecutive year Cambrex has been acknowledged with an award. “Cambrex is honored to be identified once again by … Continued

Novari Health Launches Surgical Overdues Management HUB Technology in Response to COVID-19 Crisis

By asianet

As the global pandemic continues to strain access to elective surgery, Novari Health has launched new technology to help manage COVID-19 surgical waiting lists in Australia and New Zealand. For the first time ever, healthcare systems now have access to an innovative tool to help manage surgical overdues. Logo – https://mma.prnewswire.com/media/1739293/Novari_Health_Inc__Novari_Health_Launches_Surgical_Overdues_Mana.jpg The COVID-19 pandemic has … Continued

Novari Health Launches Surgical Waiting List Management HUB Technology in Response to COVID-19 Crisis

By asianet

As the global pandemic continues to strain access to elective surgery, Novari Health has launched new technology to help manage surgical waiting lists in New Zealand and Australia. For the first time ever, healthcare systems now have access to an innovative tool to help manage surgical waiting lists. Logo – https://mma.prnewswire.com/media/1739294/Novari_Health_Inc__Novari_Health_Launches_Surgical_Waiting_List.jpg The COVID-19 pandemic has … Continued

The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster

By asianet

– Sputnik Light will be an important part of India’s vaccination program and the fight against mutations of COVID, including Omicron. – Sputnik Light has been authorized in more than 30 countries with total population of over 2.5 billion people. The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the Russian one-shot Sputnik … Continued

New Zealand’s Medsafe Grants Provisional Approval for Novavax’ COVID-19 Vaccine

By asianet

— Nuvaxovid(TM) is the first protein-based COVID-19 vaccine to receive provisional approval for distribution in New Zealand Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that New Zealand’s Medsafe has granted provisional approval of NVX-CoV2373, Novavax’ COVID-19 vaccine (adjuvanted), for active immunization to … Continued

Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain*

By asianet

— Nuvaxovid(TM) COVID-19 Vaccine (recombinant, adjuvanted)(+) is the first protein-based COVID-19 vaccine authorized in Great Britain — Novavax and the U.K. Vaccines Taskforce previously announced an agreement for up to 60 million doses — Authorization based on data including an ongoing pivotal Phase 3 trial conducted in the U.K. with almost 15,000 participants Novavax, Inc. … Continued

Formus Labs Raises $5 Million to Automate Orthopedic Surgery Planning; Partners With Zimmer Biomet to Supercharge Global Distribution

By asianet

— Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D models to optimize the preoperative planning process Formus Labs ( https://c212.net/c/link/?t=0&l=en&o=3429651-1&h=1880905409&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3429651-1%26h%3D3397578166%26u%3Dhttps%253A%252F%252Fwww.formuslabs.com%252F%26a%3DFormus%2BLabs&a=Formus+Labs ), the world’s first automated 3D planner for joint replacement surgeries, today announced it has raised US $5 million (USD) and the public launch of its orthopedic surgery planning solution … Continued